A randomized, double-blind, placebo-controlled, double-dummy study to determine the safety/tolerability of a simultaneous subcutaneous treatment of BM41 and vitamin D3 in patients with moderate to severe allergic rhinitis/ rhinoconjunctivitis caused by birch pollen.
NL-OMON45256
Academisch Medisch Centrumallergic rhinitis
birchpollen allergy
Target: 40Updated: 2024-02-28